Adaptive Biotechnologies Corp
ADPT
Revenue
43.19M
▲1.32M▲3.15%
3 Months ChangeAssets
584.87M
▼-35.45M▼-5.71%
3 Months ChangeLiabilities
343.44M
▼-2.12M▼-0.6121%
3 Months ChangeFree Cash Flow
-39.86M
▲22.21M▲35.78%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-08-01
Form 10-Q
ID: 0000950170-24-089342
2024-08-01
Form 8-K
ID: 0000950170-24-089301
2024-06-11
Form 8-K
ID: 0000950170-24-071913
2024-05-07
Form 10-Q
ID: 0000950170-24-054604
2024-05-07
Form 8-K
ID: 0000950170-24-054513
2024-04-09
Form 8-K
ID: 0001193125-24-090983
2024-04-05
Form 8-K
ID: 0000950170-24-042291
2024-04-02
Form 8-K
ID: 0001193125-24-084748
2024-02-14
Form 8-K
ID: 0000950170-24-015230
2023-11-09
Form 10-Q
ID: 0000950170-23-062136